Detailed Result for NCT04937907
NCT ID: | NCT04937907 |
---|---|
NLM Download Date Description: | N/A |
Study First Submitted Date: | 2021-06-17 |
Last Update Submitted Date: | 2021-09-08 |
Last Update Submitted Date: | 2021-09-08 |
Result First Submitted Date: | N/A |
Disposition First Submitted Date: | N/A |
Start Month Year: | September 8, 2021 |
Start Date: | 2021-09-08 |
Start Date Type: | Actual |
Verification Month Year: | September 2021 |
Verification Date: | 2021-09-30 |
Completion Month Year: | June 30, 2023 |
Completion Date: | 2023-06-30 |
Completion Date Type: | Anticipated |
Primary Completion Month Year: | December 31, 2022 |
Primary Completion Date: | 2022-12-31 |
Primary Completion Date Type: | Anticipated |
Study first Submitted QC Date: | 2021-06-17 |
Study first posted Date: | 2021-06-24 |
Result first Submitted QC Date: | N/A |
Result First Posted Date: | N/A |
Disposition First Submitted QC Date: | N/A |
Disposition First Posted Date: | N/A |
Last Updated Submitted QC Date: | 2021-09-08 |
Last Updated Posted Date: | 2021-09-16 |
Target Duration: | N/A |
Study Type: | Interventional |
Acronym: | CHXLAS |
Baseline Population: | N/A |
Brief Title: | Study of Hydroxychloroquine in Patients With X-linked Alport Syndrome in China (CHXLAS) |
Official Title: | Efficacy and Safety of Hydroxychloroquine in Patients With X-linked Alport Syndrome in China (CHXLAS) |
Overall Status: | Recruiting |
Last Known Status: | N/A |
Phase: | Phase 2 |
Enrollment: | 50 |
Enrollment Type: | Anticipated |
Source: | Shanghai Children's Hospital |
Limitation and Caveats: | N/A |
Number of Arms: | 2 |
Number of Groups: | N/A |
Why Stopped: | N/A |
Has Expanded Access: | N/A |
Expanded Access Type Individual: | N/A |
Expanded Access Type Intermediate: | N/A |
Expanded Access Type Treatment: | N/A |
Has DMC: | N/A |
Is it FDA Regulated Drug: | N/A |
Is it FDA Regulated Device: | N/A |
Is it Unapproved Device: | N/A |
Is PPSD: | N/A |
Is US Export: | N/A |
Is Biospec Retention: | N/A |
Biospec Description: | N/A |
Plan to Share IPD: | No |
Plan to Share IPD Description: | N/A |
IPD Time Frame: | N/A |
IPD Access Criteria: | N/A |
IPD URL: | N/A |